Study of High Efficient Killing Cell Therapy for Advanced NSCLC

Clinical trial NCT03193567 · RECRUITING

Trial details

NCT number: NCT03193567
Sponsor: Ruijin Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer

Start date: 2017-09-14
Primary completion: 2025-05-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.